Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (10): 901-903.DOI: 10.3969/j.issn.1673-8640.2017.010.016
• Orginal Article • Previous Articles Next Articles
Received:2016-11-28
Online:2017-10-20
Published:2017-11-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.010.016
| 胸腔积液类型 | 靶细胞 | CK | Vim | CK7 | CK20 | TTF-1 | NapSinA | CR | CEA | CK5 |
|---|---|---|---|---|---|---|---|---|---|---|
| 恶性 | 癌细胞 | 16/16 | 7/16 | 13/13 | 1/13 | 11/16 | 11/16 | 1/14 | 9/11 | 1/5 |
| 良性 | 间皮细胞 | 5/5 | 5/5 | 3/3 | 0/3 | 0/5 | 0/5 | 5/5 | 0/5 | 5/5 |
| 胸腔积液类型 | 靶细胞 | CK | Vim | CK7 | CK20 | TTF-1 | NapSinA | CR | CEA | CK5 |
|---|---|---|---|---|---|---|---|---|---|---|
| 恶性 | 癌细胞 | 16/16 | 7/16 | 13/13 | 1/13 | 11/16 | 11/16 | 1/14 | 9/11 | 1/5 |
| 良性 | 间皮细胞 | 5/5 | 5/5 | 3/3 | 0/3 | 0/5 | 0/5 | 5/5 | 0/5 | 5/5 |
| 胸腔积液类型 | 例数 | DNA异倍体 细胞 | TCT涂片 癌细胞 | 合计 |
|---|---|---|---|---|
| 恶性 | 25 | 20（80.00） | 13（52.00） | 25（100.00） |
| 良性 | 77 | 5（6.49） | 0（0.00） | 5（6.49） |
| 胸腔积液类型 | 例数 | DNA异倍体 细胞 | TCT涂片 癌细胞 | 合计 |
|---|---|---|---|---|
| 恶性 | 25 | 20（80.00） | 13（52.00） | 25（100.00） |
| 良性 | 77 | 5（6.49） | 0（0.00） | 5（6.49） |
| DNA异倍体 细胞类型 | 恶性胸 腔积液 | 良性胸 腔积液 | 合计 |
|---|---|---|---|
| 阳性 | 20（80.00） | 5（6.49） | 25 |
| 阴性 | 5（20.00） | 72（93.51） | 77 |
| 合计 | 25 | 77 | 102 |
| DNA异倍体 细胞类型 | 恶性胸 腔积液 | 良性胸 腔积液 | 合计 |
|---|---|---|---|
| 阳性 | 20（80.00） | 5（6.49） | 25 |
| 阴性 | 5（20.00） | 72（93.51） | 77 |
| 合计 | 25 | 77 | 102 |
| 胸腔积液类型 | DNA倍体分析 | TCT涂片 | 2种方法联合应用 | |||||
|---|---|---|---|---|---|---|---|---|
| 阳性 | 阴性 | 阳性 | 阴性 | 阳性 | 阴性 | |||
| 恶性 | 20 | 5 | 13 | 12 | 25 | 0 | ||
| 良性 | 5 | 72 | 0 | 77 | 5 | 72 | ||
| 胸腔积液类型 | DNA倍体分析 | TCT涂片 | 2种方法联合应用 | |||||
|---|---|---|---|---|---|---|---|---|
| 阳性 | 阴性 | 阳性 | 阴性 | 阳性 | 阴性 | |||
| 恶性 | 20 | 5 | 13 | 12 | 25 | 0 | ||
| 良性 | 5 | 72 | 0 | 77 | 5 | 72 | ||
| [1] | 李兴华,葛亮,赵云芳.胸腔积液CYFRA21-1、NSE联合检测对肺癌诊断的临床意义[J]. 中国实验诊断学,2010,14(7):1102-1103. |
| [2] | LIGHT R W,MACGREGOR M I,LUCHSINGER P C,et a1. Pleural effusions:the diagnostic separation of transudates and exudates[J]. Ann Intern Med,1972,77(4):507-513. |
| [3] | 吴京,谢惠英,葛歆悦,等. 腺苷脱氨酶和癌胚抗原联合检测在结核性与恶性肿瘤胸腔积液鉴别诊断上的价值[J]. 检验医学,2014,29(6):688-689. |
| [4] | UGURLUOGLU C,KURTIPEK E,UNLU Y,et al.Importance of the cell block technique in diagnosing patients with non-small cell carcinoma accompanied by pleural effusion[J]. Asian Pac J Cancer Prev,2015,16(7):3057-3060. |
| [5] | CHITTURI R T,NIRMAL R M,SUNIL P M,et al.Evaluation of ploidy status using DNA-image cytometry of exfoliated mucosal cells in oral lichen planus[J]. J Cytol,2014,31(3):131-135. |
| [6] | BRADLEY G,ODELL E W,RAPHAEL S,et al.Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma[J]. Br J Cancer,2010,103(9):1432-1442. |
| [7] | 杨倩. 脱落细胞学检查、DNA 倍体分析与血清肿瘤标志物联合检测诊断恶性胸腹水的价值[J]. 蚌埠医学院学报,2015,40(8):1046-1048. |
| [8] | YAN J,WEI Q,JIAN W,et al.A fine decision tree consisted of CK5/6,IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells,metastatic adenocarcinoma of lung and non-lung origin in pleural effusion[J]. Int J Clin Exp Pathol,2014,7(9):5810-5818. |
| [9] | SHI H Z,LIANG Q L,JIANG J,et al.Diagnostic value of carcinoembryonic antigen in malignant pleural effusion:a meta-analysis[J]. Respirology,2008,13(4):518-527. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
